TREATMENT FOR RETINAL DISORDERS

Compositions in the treatment of retinal disorders include a phosphorothioate oligonucleotide in a therapeutically effective amount. The phosphorothioate oligonucleotide is administered in the treatment of retinal disorders. Wherein the pharmaceutical composition comprises a therapeutically effectiv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	ZORZÓPULOS, Jorge
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Compositions in the treatment of retinal disorders include a phosphorothioate oligonucleotide in a therapeutically effective amount. The phosphorothioate oligonucleotide is administered in the treatment of retinal disorders. Wherein the pharmaceutical composition comprises a therapeutically effective amount of a phosphorothioate oligonucleotide comprising a nucleic acid sequence of at least a 70% sequence identity to SEQ ID NO: 1. Les compositions pour le traitement de troubles rétiniens comprennent un oligonucléotide de phosphorothioate en une quantité thérapeutiquement efficace. L'oligonucléotide de phosphorothioate est administré dans le traitement de troubles rétiniens.